A template that clinics have used successfully: Subject: An update on your compounded medication Dear [Patient First Name], As part of our continued commitment to compliant, high-quality compounded medications, your next prescription will be filled by a different pharmacy partner in our network
The main treatments are surgery, chemoradiotherapy and immunotherapy, but the prognosis is poor and drug resistance and toxic side effects reduce the effectiveness of these treatments 2
FDA) Orange Book and those asserted in litigation (where applicable), statements made by companies in their SEC filings or in press releases, as well as journal articles that provided analysis of the drugs and related patent information to determine the expiry date for the primary patents on each drug
Mechanistic specificity
PD-1/PD-L1 checkpoint-blocking antibodies are thought to act primarily in the tumor microenvironment, where PD-L1 is expressed by tumor cells (174), myeloid cells (168, 203, 204), LECs (94, 95, 98), blood endothelial cells (95), B cells (205, 206), T cells (207), dendritic cells (203) and NK cells (208, 209)
